Levocetirizine Dihydrochloride
- Product NDC
- 43063-831
- 11-digit product format
- 430630831
- Labeler code
- 43063
- Product ID
- 43063-831_a44a2a39-22d0-5592-e053-2995a90a5785
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Levocetirizine Dihydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Application
- ANDA203027
- Marketing category
- ANDA
- Marketing start
- 2015-02-13
- Marketing end
- 2021-03-01
- Substance
- LEVOCETIRIZINE DIHYDROCHLORIDE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 43063-831-30 | 43063083130 | 30 TABLET in 1 BOTTLE, PLASTIC (43063-831-30) | 30 tablet | 2018-01-29 | 2021-03-01 | No | No | Current |